Compare GEHC & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | CNC |
|---|---|---|
| Founded | 1892 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 33.5B |
| IPO Year | 2022 | 2001 |
| Metric | GEHC | CNC |
|---|---|---|
| Price | $61.06 | $63.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $88.38 | $46.75 |
| AVG Volume (30 Days) | ★ 4.3M | 2.9M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | ★ 4.84 | N/A |
| EPS | 0.85 | ★ 3.11 |
| Revenue | $20,625,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $7.12 | $8.31 |
| Revenue Next Year | $4.45 | $1.05 |
| P/E Ratio | $72.93 | ★ $20.49 |
| Revenue Growth | 4.84 | ★ 19.44 |
| 52 Week Low | $58.75 | $25.08 |
| 52 Week High | $89.77 | $69.36 |
| Indicator | GEHC | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 45.36 |
| Support Level | $60.17 | $63.20 |
| Resistance Level | $65.83 | $69.32 |
| Average True Range (ATR) | 1.89 | 2.24 |
| MACD | -0.33 | -0.68 |
| Stochastic Oscillator | 18.40 | 5.54 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.